- €100.89m
- €256.04m
- €18.99m
- 29
- 52
- 42
- 32
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.64 | 1.7 | 9.52 | 15.1 | 19 |
Cost of Revenue | |||||
Gross Profit | — | — | 8.29 | 11.2 | 13.6 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 7.71 | 0.017 | -1.63 | -4.23 | 5.5 |
Operating Profit | -6.07 | 1.69 | 11.2 | 19.3 | 13.5 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 39.5 | 1.38 | 9.57 | 16.2 | 8.69 |
Provision for Income Taxes | |||||
Net Income After Taxes | 41.7 | 2.41 | 14.6 | 15.9 | 7.24 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 46.2 | 27.6 | 14.6 | 16 | 7.25 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 46.2 | 27.6 | 14.6 | 16 | 7.25 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 19.8 | 0.146 | 0.234 | 0.239 | 0.087 |
Dividends per Share |